Translation of "cumulative recovery system " (English → French) :

- Finally, five inspections of the management of the cumulative recovery system in the rice sector were carried out in 1999 in France, Germany, the Netherlands, the United Kingdom and Belgium.

Mention should also be made of the action taken to follow up the inspection of the management of the cumulative recovery system in the rice sector (CRS) [25] which progressed considerably during the reference period.

- Finally, five inspections of the management of the cumulative recovery system in the rice sector were carried out in 1999 in France, Germany, the Netherlands, the United Kingdom and Belgium.

Whereas Commission Regulation (EC) No 703/97 (3), as amended by Regulation (EC) No 1403/97 (4), introduces a cumulative recovery system (CRS) for determining certain import duties on husked rice for a trial period from 1 July 1997 to 30 June 1998; whereas, in view of the lack of results for the two trial periods laid down for that system, it cannot be assessed; whereas, as a result, the CRS should be extended for an additional trial period from the entry into force of this Regulation to 31 December 1998;

COMMISSION REGULATION (EC) No 1470/98 of 1 July 1998 extending for an additional trial period the cumulative recovery system in the rice sector introduced by Regulation (EC) No 703/97

The key deliverables of the initiative include an assessment of the TPP cost-recovery initiative as it relates to the Treasury Board cost-recovery policy, and the public and private benefits that have derived from it; a thorough assessment of the current cost-recovery initiative costing model used by the TPP, including a comparison of other regulatory regimes and justifications, identification of any gaps in the current cost-recovery initiative, and the contribution of fees to the delivery of an efficient service; an evaluation of whether the cost-recovery initiative has had an impact on the TPP's performance, taking into consideration ...[+++] previous performance commitments, other jurisdictions' experience, options for improving feedback and/or communication mechanisms for stakeholders to foster transparency and accountability, and constraints that might limit my program's ability to manage the cost-recovery initiative and thereby the efficient operations of its programs; an assessment of the direct, indirect, and cumulative impacts of the cost-recovery initiative on therapeutic products industries, on consumers and the health care system, and on the TPP itself, and the development of a rigorous methodology and relevant data sources for a follow-up assessment of the impact of planned fees on the medical devices regulation area; and finally, a systematic review of lessons learned from other jurisdictions and options for operational and/or organizational alternatives and/or modifications to improve the management of the TPP cost recovery initiative.